• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 79 of 100
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange
HealthSamsung’s Drug Group Is Taking AbbVie to Court in Biotech Copycat Push
By ReutersApril 4, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
HealthNovartis Takes Entresto Case to U.S. Cardiologist Meeting
By ReutersApril 2, 2016
Doctors Without Borders Protests High Cost Of Vaccines
FinancePfizer Just Got Pranked Big Time Before April Fool’s Day Even Started
By Jen WiecznerMarch 31, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceBill Ackman Can’t Sell Valeant Even If He Wants To
By Lucinda ShenMarch 31, 2016
483106863
HealthGlaxoSmithKline Is Expanding Drug Access to the World’s Poorest Countries
By Sy MukherjeeMarch 31, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
HealthWatchdog Says U.S. Big Pharma Isn’t Paying Enough for Breaking the Law
By ReutersMarch 31, 2016
RU486
HealthFDA Enters the Abortion Debate Fray With Latest Decision
By Laura LorenzettiMarch 30, 2016
BRITAIN-PHARMACEUTICAL-GSK
HealthHere’s How GlaxoSmithKline’s CEO Thinks Pharma Should Modernize
By Sy MukherjeeMarch 30, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
FinanceValeant Is Asking its Lenders for More Time to File its Annual Report
By ReutersMarch 30, 2016
The U.S. and Europe Could Save $110 Billion With Copycat Biotech Drugs
HealthThe U.S. and Europe Could Save $110 Billion With Copycat Biotech Drugs
By ReutersMarch 29, 2016
503920324
FinanceWhy Acadia Pharma’s Shares Are Popping Today
By Sy MukherjeeMarch 28, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceValeant’s CEO Will Have to Testify at a U.S. Congressional Hearing
By ReutersMarch 28, 2016
Woman With Headache
HealthHere’s Why Alder Pharmaceutical’s Stock Is Booming
By Laura LorenzettiMarch 28, 2016
166274033
HealthBig Pharma Is Taking Its Policy Agenda Straight to Lawmakers
By Sy MukherjeeMarch 28, 2016
US-ENTERTAINMENT-FESTIVAL-TRIBECA
Arts & EntertainmentRobert De Niro Pulls Controversial Anti-Vaccine Film From Tribeca Film Festival
By TIMEMarch 27, 2016
1...
  • 77
  • 78
  • 79
  • 80
  • 81
...100
Most Popular
Future of Work
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top collegesplaceholder alt text
By Jake AngeloMay 9, 2026
Politics
Ted Cruz says the quiet part out loud: Trump accounts are Social Security personal accounts as GOP senator reveals 'dirty little secret'placeholder alt text
By Jason MaMay 9, 2026
Economy
‘This is the way’: Elon Musk endorses Warren Buffett’s famed 5-minute plan to fix the national debtplaceholder alt text
By Jacqueline MunisMay 10, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.